WeVote
Log In

Bill

Bill

A 26

Prohibits Medicaid from requiring prior authorization for certain HIV medications

2025 Regular Session Introduced by Linda Rosenthal

Bill A 26 allows Medicaid recipients with HIV to access essential medications without prior authorization, ensuring timely treatment and reducing administrative burdens.

RETURNED TO ASSEMBLY
0
WeVote Research Nonpartisan
Bill Summary · A 26

Summary of Bill A 26: Prohibiting Prior Authorization for Certain HIV Medications

Bill Overview

  • Bill Number: A 26
  • Title: Prohibits Medicaid from requiring prior authorization for certain HIV medications
  • Status: Returned to Assembly
  • Introduced: January 08, 2025
  • Classification: Bill

Purpose and Intent

The primary purpose of Bill A 26 is to streamline access to essential HIV medications for individuals enrolled in Medicaid. By eliminating the requirement for prior authorization, the bill aims to reduce barriers to treatment, ensuring that patients can receive timely and uninterrupted access to life-saving medications.

Key Provisions

  • Elimination of Prior Authorization: The bill specifically prohibits Medicaid from requiring prior authorization for certain HIV medications. This change is intended to expedite the process through which patients can obtain their prescriptions.
  • Focus on Essential Medications: While the bill does not specify which medications are included, it is understood that the intent is to cover a range of antiretroviral therapies critical for managing HIV.

Affected Parties

  • Medicaid Recipients: Individuals with HIV who are enrolled in Medicaid will benefit directly from this legislation, as it will facilitate quicker access to necessary medications.
  • Healthcare Providers: Physicians and pharmacists will experience a reduction in administrative burdens associated with prior authorization requests, allowing them to focus more on patient care.
  • Pharmaceutical Companies: Manufacturers of HIV medications may see changes in prescription patterns as access improves.

Legislative Timeline

  • January 08, 2025: Bill introduced and referred to the Health Committee.
  • April 08, 2025: Reported and referred to the Ways and Means Committee.
  • May 20, 2025: Reported and referred to Rules.
  • May 27, 2025: Bill reported and ordered to third reading.
  • June 05, 2025: Passed in the Assembly and delivered to the Senate.
  • June 12, 2025: Substituted for S 5534, passed in the Senate, and returned to the Assembly.

Related Legislation

  • A 10716: A related bill from the prior session that may address similar issues regarding Medicaid and HIV treatment.
  • S 5534: A companion bill that aligns with the objectives of A 26, focusing on the same provisions regarding prior authorization.

Conclusion

Bill A 26 represents a significant step towards improving healthcare access for individuals living with HIV by removing prior authorization requirements for essential medications under Medicaid. The bill's progress through the legislative process reflects a growing recognition of the need for timely and effective treatment options for vulnerable populations.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.